𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S1939 Viral Kinetics and Pharmacodynamics of Albinterferon Alfa-2b in Interferon Treatment-NaïVe Patients with Genotype 1, Chronic Hepatitis C

✍ Scribed by Neumann, Avidan U.; Rozenberg, Lynn; Bain, Vincent G.; McHutchison, John G.; Pulkstenis, Erik; Subramanian, Mani


Book ID
122610992
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
97 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Albinterferon alfa-2b dosed every two or
✍ Stefan Zeuzem; Eric M. Yoshida; Yves Benhamou; Stephen Pianko; Vincent G. Bain; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The efficacy and safety of albinterferon alfa-2b (alb-IFN), a novel recombinant protein consisting of interferon alfa-2b genetically fused to human albumin, was evaluated in a phase 2b, open-label study of patients with genotype 1, chronic hepatitis C. In all, 458 IFN-alfa treatment-naı ¨ve patients